<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Thyroid cancer":28,
"clinical management":1,
"endocrine pathology":1,
"endocrine surgery":1,
"molecular marker":1,
"telomerase reverse transcriptase expression":1,
"telomerase reverse transcriptase hypermethylation":1,
"telomerase reverse transcriptase promoter mutation":1,
"99mTc-pertechnetate":1,
"radioiodine":4,
"salivary gland dynamic scintigraphy":1,
"Iran":2,
"Papillary thyroid carcinoma":27,
"central neck lymph nodes":1,
"disease-free survival":1,
"lymph node ratio":1,
"recurrence":6,
"encapsulated follicular variant of papillary thyroid carcinoma":2,
"noninvasive follicular thyroid neoplasm with papillary-like nuclear features":2,
"pediatric":1,
"Colon adenocarcinoma":1,
"Metastasis":6,
"NIFTP":4,
"Adenocarcinoma of lung":1,
"Diffuse sclerosing variant of papillary thyroid carcinoma":1,
"Napsin A":1,
"Occult cancer":1,
"PAX8":1,
"Cancer":3,
"Mutation":1,
"Promoter":1,
"TERT":3,
"Extracellular acidification rate":1,
"Pancreatic cancer":1,
"TWIST1":1,
"Transcription factor":3,
"Warburg effect":1,
"Transthyretin":1,
"endocytosis":1,
"epidermoid carcinoma":1,
"membrane receptors":1,
"prealbumin":1,
"transferrin":1,
"Head and neck neoplasms":1,
"guideline adherence":1,
"hypothyroidism":3,
"quality improvement":1,
"radiotherapy":1,
"Biopsy, fine-needle":1,
"Gene rearrangement":1,
"Humans":1,
"Sarcoma, alveolar soft part":1,
"Thyroid gland":3,
"biomarker":1,
"mass spectrometry":1,
"site-specific N-glycopeptide":1,
"Extensive venous invasion":1,
"Follicular thyroid carcinoma":2,
"Internal jugular vein":1,
"Staged surgical approach":1,
"Superior vena cava":1,
"Tumor thrombus in the atrium":1,
"Esophagus":1,
"Gastric":1,
"Gastroesophageal":1,
"Hyperthyroidism":1,
"Thyroxine":1,
"levothyroxine":1,
"lobectomy":2,
"recur":1,
"Differentiated thyroid cancer":2,
"Preoperative":1,
"Thyroid carcinoma":5,
"Thyroid nodules":3,
"Thyroid-stimulating hormone":1,
"DCAF16":1,
"IHC":1,
"adenocarcinoma":1,
"squamous cell carcinoma":2,
"basal cell carcinoma":1,
"calvarium invasion":1,
"diploic space invasion":1,
"radiographic imaging":1,
"scalp invasion":1,
"Multinodular goiter":1,
"Solitary thyroid nodule":1,
"Cervical lymph node":1,
"Intermediate risk":1,
"Predictive factors":2,
"PSMD10":1,
"SNHG3":1,
"miR-214-3p":1,
"Kidney failure, chronic":1,
"Neoplasms":2,
"Renal dialysis":1,
"L-GILZ":1,
"MAPK":1,
"MAPK pathway–inhibiting drugs":1,
"NF-κB":1,
"Proliferation":1,
"RAS mutation":1,
"MUC5AC":1,
"heterogeneity":1,
"lung adenocarcinoma with mucin production":1,
"prognosis":11,
"18F-FDG PET/CT":2,
"Elderly, ultrasonography risk stratification systems":1,
"Thyroid cytology":1,
"TCF1":1,
"m6A":1,
"methyltransferase METTL3":1,
"migration":1,
"Angioinvasion":1,
"Capsular invasion":1,
"Extrathyroidal extension":2,
"Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP)":1,
"Vascular invasion":1,
"Hyperparathyroidism":1,
"Therapeutic outcomes":1,
"Medullary carcinoma":1,
"Neck dissection":6,
"Survival":4,
"Magnetic resonance imaging":2,
"Neoplasm staging":1,
"Ultrasonography":7,
"ATP binding cassette subfamily D member 3":1,
"Gene Expression Omnibus":1,
"The Cancer Genome Atlas":1,
"bioinformatics analysis":1,
"colorectal carcinoma":1,
"diagnosis":6,
"Hypoparathyroidism":1,
"Lymph node":4,
"Breast cancer":4,
"Cruciferous vegetables":1,
"Glucosinolates":1,
"Glutathione S-transferase polymorphisms":1,
"Isothiocyanates":1,
"iodine 131":1,
"sialadenitis":1,
"ultrasound":4,
"whole-body scintigraphy":1,
"BRAFV600E mutation":1,
"biomarkers":1,
"papillary thyroid carcinoma (PTC), miRNA":1,
"Crowdfunding":1,
"Social media":1,
"Thyroid surgery":2,
"Thyroid neoplasms":14,
"Blood flow signal":1,
"Central lymph node metastasis":2,
"Maximum value of elastic modulus":1,
"Scoring system":1,
"Iodine radioisotopes":1,
"Papillary thyroid cancer":8,
"Prognoses":1,
"TNM staging systems":1,
"aggressive thyroid cancer":1,
"stair-step procedure":1,
"tracheal resection":3,
"tracheoesophageal invasion":1,
"BRAFV600E":2,
"Immunohistochemistry":2,
"Meta-analysis":3,
"PDOX":1,
"TNBC":1,
"cisplatinum":1,
"eribulin":1,
"matrix-producing breast carcinoma":1,
"patient-derived orthotopic xenograft":1,
"triple-negative breast cancer":1,
"tumor regression":1,
"axillary lymph node metastasis":1,
"breast invasive ductal carcinoma":1,
"contrast-enhanced ultrasound":1,
"conventional ultrasound":1,
"doubling time":1,
"thyroglobulin":1,
"Neuropilin":1,
"FDG":2,
"PET-CT":1,
"Staging":1,
"Adrenal sparing surgery":1,
"Adrenalectomy":1,
"Medullary thyroid cancer":1,
"Multiple endocrine neoplasia type 2":2,
"Pheochromocytoma":2,
"RET":1,
"DNA methylation":1,
"TETs":1,
"American Joint Committee on Cancer (AJCC)":1,
"Follicular variant of papillary thyroid carcinoma (FVPTC)":1,
"Surveillance, Epidemiology, and End Results (SEER)":1,
"risk stratification":1,
"staging system":1,
"invasive ductal breast cancer":1,
"neurofibromatosis 1":1,
"oncology":1,
"Colon Cancer":1,
"HCC":2,
"Metabolic Syndrome":1,
"Smoking":1,
"Medullary thyroid carcinoma":9,
"Bethesda system":1,
"FNA":1,
"cytopathology":1,
"thyroid":7,
"BRAF V600E":1,
"Indolent":1,
"Bethesda":1,
"Fine needle aspiration (FNA)":1,
"central neck dissection":2,
"follicular neoplasia":1,
"Thyroseq":2,
"indeterminate thyroid nodules":2,
"Gross extrathyroidal extension":1,
"Papillary carcinoma":3,
"Tumor-node-metastasis staging system":1,
"Endocrine":2,
"Papillary thyroid carcinoma follicular thyroid carcinoma":1,
"Pediatric thyroid surgery":1,
"FNAC":1,
"TI-RADS":1,
"Thyroid nodule":6,
"Multiple parathyroid adenoma":1,
"Parathyroid adenoma":2,
"Parathyroid carcinoma":1,
"Primary hyperparathyroidism":2,
"cost-effectiveness":1,
"economic evaluation":1,
"laryngoscopy":1,
"vocal fold paralysis":1,
"M2-like tumor-associated macrophages":1,
"Wnt/β-catenin pathway":1,
"Zoledronic acid (ZA)":1,
"Morbidity":3,
"Neuromonitoring":1,
"Recurrent laryngeal nerve":1,
"TOETVA":1,
"Thyroidectomy":7,
"Transoral endocrine surgery":1,
"Transoral endoscopic thyroidectomy vestibular approach":1,
"Transoral thyroidectomy":2,
"COVID-19":1,
"Pandemic":1,
"SARS-CoV-2":2,
"Compression symptoms":1,
"Fine needle aspiration cytology":2,
"Operative indications":1,
"Thyroid imaging reporting and data system":1,
"Forecasting":1,
"Lymphatic metastasis":1,
"Nomogram":1,
"cervical disc surgery":1,
"neck lymphatic metastasis":1,
"occult thyroid carcinoma":1,
"Hirschsprung disease":1,
"Multiple endocrine neoplasia 2B":1,
"Multiple mucosal neuroma":1,
"Proto-oncogene":1,
"antecedents of other diseases":1,
"cytologic features":1,
"relative prevalence of Hurthle cell cancer":1,
"risk levels":1,
"thyroid cancer histotypes":1,
"primary health care":1,
"survivorship":1,
"BRAF":3,
"Oncocytic":1,
"Radioactive iodine":1,
"Lymph Node Metastases":1,
"Postoperative Nonstimulated Thyroglobulin":1,
"Balance":1,
"Dysphonia":1,
"Posturographic analysis":1,
"Stabilometric":1,
"Vocal disorders":1,
"gene":1,
"retrotransposon Gag like 4":1,
"chromosomes":1,
"genes, neoplasm":1,
"genetics":1,
"suprahyoid retropharyngeal lymph node":1,
"transcervical dissection":1,
"fine needle aspiration parathyroid":1,
"intrathyroidal parathyroid carcinoma":1,
"intrathyroidal parathyroid lesions":1,
"parathyroid cytology":1,
"PLEKHS1":1,
"prognostic factors":1,
"promoter mutations":1,
"lymphovascular invasion":1,
"false positive":1,
"mucinous adenocarcinoma":1,
"ovary":2,
"Multicentric":1,
"papillary thyroid carcinoma (PTC)":2,
"99m Tc-octreotide scintigraphy":1,
"whole-body iodine":1,
"mRNAs":1,
"GAS5":1,
"diagnostic biomarker":1,
"long non-coding RNA":1,
"therapeutic targe":1,
"tumor suppressor gene":1,
"remote‐access thyroidectomy":1,
"robotic thyroidectomy":1,
"selective neck dissection":1,
"Carcinoma":4,
"Drug therapy":1,
"Multidetector computed tomography":1,
"Pancreatic ductal":1,
"Treatment outcome":2,
"Cancer stem-like cells":1,
"Metastatic thyroid carcinoma":1,
"Regenerative potential":1,
"Single-cell RNA sequencing":1,
"Thyroid follicular epithelial cells":1,
"Liver X receptors":1,
"Metabolism":1,
"Obesity":1,
"Ribosomes":1,
"cause of death":1,
"clinical course":1,
"distant metastasis":1,
"overall survival":1,
"well-differentiated thyroid cancer":1,
"Graves' disease":1,
"Hashimoto's thyroiditis":2,
"Asia-Pacific":1,
"sensitivity and specificity":1,
"neck ultrasound":1,
"surgeon-performed ultrasound":1,
"biopsy":1,
"fine needle":1,
"large-core needle":1,
"China":1,
"Covid19":1,
"Italy":1,
"Recurrent laryngeal nerve palsy":1,
"South Korea":1,
"Surgery":1,
"Surgical practice":1,
"Genitourinary":1,
"papillary carcinoma of thyroid":1,
"sarcoidosis":1,
"8505C cell line":1,
"BCPAP cell line":1,
"CFLAR":1,
"IL6":1,
"SPINT2":1,
"apoptosis":1,
"oxidative phosphorylation":1,
"thyroid hormone synthesis":1,
"weighted pathway regulation":1,
"Anaplastic thyroid carcinoma":2,
"bioinformatics":2,
"malignancy":1,
"regulatory network":1,
"collagen capsule":1,
"differential diagnosis":1,
"quantitative analysis":1,
"second harmonic generation microscopy":1,
"Chronic lymphocytic thyroiditis":1,
"N-stage":1,
"SEER":1,
"Synergistic effects":1,
"renal cell carcinoma":2,
"tumour-to-tumour metastasis":1,
"ATC":1,
"anaplastic thyroid cancer":1,
"hypofractionated":1,
"irradiation":1,
"miR-146b":1,
"miR-181b":1,
"miR-21":1,
"miR-221":1,
"miR-222":1,
"plasma":1,
"CD73":1,
"ecto-5′-nucleotidase":1,
"inflammation":1,
"DLEU1":1,
"ROCK1":1,
"miR-421":1,
"robotic surgical procedures":1,
"Discoloration":1,
"Head and neck cancer":2,
"Tetracycline":1,
"Head and neck carcinoma":1,
"Maxillary sinus":1,
"Merkel cell carcinoma":1,
"Merkel cell polyomavirus":1,
"Nasal cavity":1,
"AJCC staging":1,
"Outcome":1,
"PTC":1,
"TCGA data":1,
"Granular cell tumor":1,
"Infundibulum":1,
"Pituicytoma":1,
"Pituitary":1,
"Pituitary ependymoma":1,
"Posterior pituitary":1,
"Posterior pituitary tumors":1,
"Sellar ependymoma":1,
"Spindle cell oncocytoma":1,
"Data set":1,
"ICCR":1,
"Protocol":1,
"Structured report":1,
"Synoptic report":1,
"FUS":1,
"LINC00893":1,
"PTEN/AKT pathway":1,
"ablation":1,
"case report":1,
"cytology":2,
"differential":1,
"medullary":1,
"Immune Escape":1,
"Immunotherapy":2,
"MHC-II":1,
"Ectopic thyroid tissue":1,
"Follicular adenoma":1,
"Goiter":1,
"Lung":1,
"Thoracoscopic surgery":1,
"metabolic networks and pathways":1,
"neuroblastoma":1,
"tumor microenvironment":1,
"fine needle biopsy":1,
"Clinical trial":1,
"Healthcare disparities":1,
"Sex":1,
"Age-dependent tumor progression":1,
"Genetic risk":1,
"Germline mutation":1,
"Lymph node metastasis":1,
"RET Proto-oncogene":4,
"modified radical neck dissection":1,
"postoperative chylothorax":1,
"postoperative complication":1,
"Head and neck cancers":1,
"Long noncoding RNAs":1,
"Receiver operating characteristic":1,
"Serum biomarker":1,
"Epigenomics":1,
"Genomics":1,
"Telomerase":1,
"Progression-free survival":1,
"Protein kinase inhibitors":1,
"Toxicity":1,
"systematic review":1,
"tracheal invasion":1,
"FOXE1":1,
"Systems biology":1,
"WGCNA":1,
"MEN2":1,
"compound mutation":1,
"hereditary medullary thyroid carcinoma":1,
"Ablation techniques":1,
"consensus":1,
"guideline":1,
"nodular goiter":1,
"Follicular thyroid adenoma":1,
"ultrasound signal":1,
"clinical N0":1,
"Hepatobiliary":1,
"Japan Association of Endocrine Surgery":1,
"active surveillance":1,
"indications":1,
"papillary thyroid microcarcinoma":1,
"strategy":1,
"task force consensus statements":1,
"breast metastasis":1,
"core biopsy":1,
"Cancer survivors":1,
"Health behavior":1,
"Sublingual and vestibular approach":1,
"Surgical procedures, minimally invasive":1,
"endoscope assisted":1,
"papillarycarcinoma":1,
"autoimmune disease":1,
"mg and autoimmune diseases":1,
"mg and graves disease":1,
"myasthenia crisis":1,
"myasthenia gravis (mg)":1,
"myasthenia gravis and thyroid disease":1,
"myopathy":1,
"thymectomy":1,
"computer-aided system":1,
"Neo-adjuvant chemotherapy":1,
"Omitting surgery":1,
"Pathological complete response":1,
"chimeric antigen receptor T-cells":1,
"EMT":1,
"epithelial-mesenchymal transition":1,
"long non-coding RNAs":1,
"miR-375":1,
"DEGs":1,
"qiagen RT2 profiler PCR arrays":1,
"signal pathways":1,
"IU1":1,
"MDM2":1,
"UPS":1,
"USP14":1,
"cervical cancer":1,
"parapharyngeal metastasis":1,
"unknown primary":1,
"RAS":1,
"cell apoptosis":1,
"cell cycle":2,
"genistein":1,
"5P strategies":1,
"precision medicine":1,
"Miliary mottling":1,
"tuberculosis":1,
"Cancer genetics":1,
"Cancer screening":1,
"Differentiated thyroid carcinoma":2,
"treatment":2,
"Cowden syndrome":1,
"PTEN mutation":1,
"Clinically node negative":1,
"Contralateral central compartment":1,
"Risk factors":4,
"review":1,
"strap muscle invasion":1,
"dosimetry parameters":1,
"intensity-modulated radiotherapy":1,
"nasopharyngeal carcinoma":1,
"predicting model":1,
"complication":1,
"microwave":1,
"radiofrequency":1,
"thermal ablation":1,
"Lenvatinib":1,
"Survival period":1,
"Electrochemotherapy":1,
"melanoma":1,
"metastases":1,
"rare non-melanoma skin cancer":1,
"MMP2":1,
"PI3K/AKT":1,
"Rab40b":1,
"cyclins":1,
"poorly differentiated thyroid cancer":1,
"radioactive iodine refractory (RAIR)":1,
"malignant struma ovarii":1,
"metastatic":1,
"Early glottic carcinoma":1,
"anterior commissure":1,
"thyroid cartilage":1,
"transoral laser microsurgery":1,
"window technique":1,
"thyroid neoplasms/surgery":1,
"thyroidectomy/methods":1,
"neuroendocrine neoplasm":1,
"peptide receptor radionuclide therapy":1,
"somatostatin analogues":1,
"AXL":1,
"CAR T":1,
"FET":1,
"FLT":1,
"PSMA":1,
"Theranostics":1,
"lung metastasis":1,
"lymphoma":1,
"mIBG":1,
"neuroendocrine tumors":1,
"non-small cell lung cancer (NSCLC)":1,
"nuclear medicine":1,
"positron emission tomography (PET)":1,
"small cell lung cancer (SCLC)":1,
"thoracic adenopathy":1,
"thymoma":1,
"age":1,
"gender differences":1,
"gross":1,
"indicator":1,
"regional characteristics":1,
"standardized":1,
"hepatocellular carcinoma":1,
"thyroid hormone":1,
"tumor progression model":1,
"Correlation":1,
"Body mass index":1,
"Radioactive iodine (RAI)":1,
"clinical practice guidelines":1,
"outpatient-based ablation":1,
"risk classification":1,
"GAS8-AS1":1,
"autophagy":1,
"lncRNA":1,
"Thyroid abscess":1,
"clinical":1,
"complications":1,
"imaging":1,
"cabozantinib":1,
"cytochrome P450":1,
"cytochrome b5":1,
"tyrosine kinase inhibitor":1,
"FATWO":1,
"cytohistology":1,
"mesonephric":1,
"Bmi1":1,
"Ink4A/Arf":1,
"Intrahepatic cholangiocarcinoma":1,
"Follicular neoplasm":1,
"Frozen section":1,
"Lateral neck metastasis":1,
"well‐differentiated thyroid carcinoma":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2020年9月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
